Position in ABBV
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$4,826,195,004
+$1,380,856,096 QoQ
Shares Held
19,178,966
+21.1% QoQ
Ownership
1.09%
of shares outstanding
% of Portfolio
0.57%
of 13F equity value
Holder Rank
#14
of 4,138 holders
Holding Since
Sep 2022
16 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Capital World Investors holds $50,250,725,849 across 10 Drug Manufacturers - General names. ABBV ranks #5 (9.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
15,902,642 | $19,074,107,484 | |
| 2 | AMGN |
Amgen Inc
|
29,075,329 | $10,528,758,137 | |
| 3 | AZN |
Astrazeneca PLC
|
30,075,134 | $5,702,846,909 | |
| 4 | GILD |
Gilead Sciences, Inc.
|
40,988,975 | $5,178,547,101 | |
| 5 | ABBV |
AbbVie Inc.
This page
|
19,178,966 | $4,826,195,004 | |
| 6 | JNJ |
Johnson & Johnson
|
15,215,015 | $3,864,157,359 | |
| 7 | PFE |
Pfizer Inc
|
22,218,190 | $535,014,015 | |
| 8 | NVO |
Novo Nordisk A S
|
5,205,926 | $249,572,092 |
All Filings in ABBV
Export CSV
16 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $4,826,195,004 | 19,178,966 | Shares | Defined | 2026-08-12 | |
| 2026-03-31 | $3,445,338,908 | 15,841,367 | Shares | Defined | 2026-05-13 | |
| 2025-12-31 | $2,986,694,239 | 13,071,444 | Shares | Defined | 2026-02-11 | |
| 2025-09-30 | $1,466,871,425 | 6,335,283 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $1,201,811,539 | 6,474,580 | Shares | Defined | 2025-08-13 | |
| 2025-03-31 | $3,387,027,616 | 16,165,653 | Shares | Defined | 2025-05-12 | |
| 2024-12-31 | $2,916,106,222 | 16,410,277 | Shares | Defined | 2025-02-13 | |
| 2024-09-30 | $3,051,270,391 | 15,451,035 | Shares | Defined | 2024-11-13 | |
| 2024-06-30 | $1,763,839,470 | 10,283,579 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $796,356,806 | 4,373,184 | Shares | Defined | 2024-05-14 | |
| 2023-12-31 | $194,157,883 | 1,252,874 | Shares | Defined | 2024-02-13 | |
| 2023-09-30 | $186,753,398 | 1,252,874 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $168,799,714 | 1,252,874 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $199,670,529 | 1,252,874 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $404,836,282 | 2,505,020 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $143,661,605 | 1,070,424 | Shares | Defined | 2022-11-14 | |
| No filing history on record for this holder in this stock. | ||||||